Collaborating to Control Tuberculosis
In collaboration with the Foundation for Innovative New Diagnostics and the Hong Kong Supranational Reference Laboratory, PATH assists the Chinese National Tuberculosis Reference Laboratory with determining the operational feasibility, cost-effectiveness, and impact of new tuberculosis diagnostics in order to help the Chinese Ministry of Health decide whether to introduce and scale up these technologies. This fact sheet is presented in English on one side and simplified Chinese on the other.
Publication date: March 2012